Atlas Trials

Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma

Clinical trial NCT00641095 · COMPLETED

Trial details

NCT number
NCT00641095
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2006-12-07
Primary completion
2011-11-23
Enrollment
370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.